Stock DIABIO DIAGONAL BIO AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Diagonal Bio AB

Equities

DIABIO

SE0015961826

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 08:53:34 26/04/2024 pm IST 		5-day change 1st Jan Change
0.0752 SEK -5.41% Intraday chart for Diagonal Bio AB -13.96% -78.70%
05/04 Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic CI
05/04 Diagonal Bio AB Announces Successful Pilot Study Results CI

Business Summary

Diagonal Bio AB is a Sweden-based medical research company. The Company is developing a diagnostic platform (Panviral) for detection of any kind of pathogen. Panviral’s technology is based on rapid isothermal amplification of a pathogen’s genome. Multiple tests can be run in parallel, thereby increasing the sample throughput.

Number of employees: 4

Sales per Business

SEK in Million2021Weight2022Weight Delta
Diagnostic Platform
100.0 %
0 100.0 % 0 100.0 % -50.12%

Sales per region

SEK in Million2021Weight2022Weight Delta
Sweden
100.0 %
0 100.0 % 0 100.0 % -50.12%

Managers

Managers TitleAgeSince
Karin Wehlin CEO
 Chief Executive Officer - 28/02
Andreas Nyberg FOU
 Founder 48 19/20/19
Bo Per Gunnar Heander DFI
 Director of Finance/CFO 60 01/21/01

Members of the board

Members of the board TitleAgeSince
Eva Nilsagård CHM
 Chairman 60 01/21/01
Kerstin Åkesson Jakobsson BRD
 Director/Board Member 68 01/21/01
Carl Edvard Georg Hall BRD
 Director/Board Member 39 01/21/01
Kushagr Punyani FOU
 Founder 33 19/20/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 679,588,243 667,789,730 ( 98.26 %) 0 98.26 %

Company contact information

Diagonal Bio AB

The Spark Medicon Village

223 81, Lund

+

http://www.diagonalbio.com
address Diagonal Bio AB(DIABIO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
DIAGONAL BIO AB Stock Diagonal Bio AB
-78.70% 2.75M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. DIABIO Stock
  4. Company Diagonal Bio AB